Menu Search
Equities

West Pharmaceutical Services Inc

WPS:DUS

West Pharmaceutical Services Inc

Actions
  • Price (EUR)301.60
  • Today's Change9.40 / 3.22%
  • Shares traded10.00
  • 1 Year change-5.81%
  • Beta--
Data delayed at least 15 minutes, as of Nov 21 2024 18:30 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

West Pharmaceutical Services, Inc. is a global manufacturer that is engaged in the design and production of technologically advanced, integrated containment and delivery systems for injectable drugs and healthcare products. The Company operates through two segments: Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers packaging, containment solutions, and drug delivery products, along with analytical lab services and other integrated services and solutions, primarily to biologic, generic and pharmaceutical drug customers. The Contract-Manufactured Products segment serves as a fully integrated business, focused on the design, manufacture, and automated assembly of complex devices, primarily for pharmaceutical, diagnostic, and medical device customers. This segment manufactures customer-owned components and devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products.

  • Revenue in USD (TTM)2.88bn
  • Net income in USD499.60m
  • Incorporated1923
  • Employees10.60k
  • Location
    West Pharmaceutical Services Inc530 Herman O. West DriveEXTON 19341United StatesUSA
  • Phone+1 (610) 594-2900
  • Fax+1 (800) 345-9800
  • Websitehttps://www.westpharma.com/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.